P3 Health Partners Inc.
PIII
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$2.99
FAIR PRICE
$4.54
MARGIN
$1.55
P/E Ratio
N/A
Div. Yield
N/A
ROE
1451.3%
Exceptional
Market Cap
$10M
Small-cap
COMING SOON
Get notified when PIII's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Aric Coffman
COUNTRY
US
HEADQUARTERS
Henderson
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate PIII's fair price
P3 Health Partners Inc.'s fair price of $4.54 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $2.99, PIII trades 51.8% below its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting PIII's risk profile.
RELATIVE · 30%
Comparing PIII's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for PIII, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate PIII's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for PIII.
Explore on BuliosFAQ
What is the fair price of PIII?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for P3 Health Partners Inc. is $4.54. At the current market price of $2.99, PIII trades 51.8% below its calculated fair value.
Is PIII overvalued or undervalued?+
P3 Health Partners Inc. is currently undervalued based on our valuation model. The stock trades at $2.99, which is 51.8% below the fair price of $4.54.
How often is PIII's fair price updated?+
We update fair price calculations for PIII daily after market close. The current fair price of $4.54 incorporates the latest market data and sector multiples.
What factors affect PIII's fair price calculation?+
PIII's fair price of $4.54 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 1451.3%.
Is PIII a good buy right now?+
At $2.99, PIII trades 51.8% below our fair value estimate of $4.54. The stock is currently undervalued. ROE stands at 1451.3% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.
Does PIII pay dividends?+
PIII does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.